Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate

Details for Australian Patent Application No. 2003288226 (hide)

International Classifications

Event Publications

1 April 2004 Complete Application Filed

Priority application(s): 102 59 912.2 20.12.02 DE

26 August 2004 Application Open to Public Inspection

Published as AU-B-2003288226

11 December 2008 Amendment Made

The nature of the amendment is: Amend the name of the inventor to read FROM: Hartig, Mareke TO: Hartig-Heimel, Mareke

7 January 2010 Application Accepted

Published as AU-B-2003288226

6 May 2010 Standard Patent Sealed

30 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.